ETF Daily News - 14:02查看原文
Virpax Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements and Makes Key Appointments
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) announced in an 8-K SEC Filing its recent developments, including regaining compliance with Nasdaq listing requirements and making significant appointments within the company.